An enhanced thirteen-week bioassay as an alternative for screening for carcinogenesis factors

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 1, 2010, Pages 15-17

  Cohen, Samuel M ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Carcinogenesis screening; Cell proliferation; Estrogen; Immunosuppression; Two year bioassay

Indexed keywords

CARCINOGEN; DNA;

ANIMAL; BIOASSAY; CARCINOGEN TESTING; CELL PROLIFERATION; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; EXPERIMENTAL NEOPLASM; HUMAN; PATHOLOGY; PROCEDURES; RISK ASSESSMENT; RODENT; TIME; TOXICITY; TRENDS;

ANIMALS; BIOLOGICAL ASSAY; CARCINOGENICITY TESTS; CARCINOGENS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DNA; HUMANS; NEOPLASMS, EXPERIMENTAL; RISK ASSESSMENT; RODENTIA; TIME FACTORS;

EID: 77955822078     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Boobis AR, Cohen SM, Dellarco V, et al (2006). IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit Rev Toxicol, 36, 781-92.
2. Cohen SM (1998a). Cell proliferation and carcinogenesis. Drug Metabolism Rev, 30, 339-57.
3. Cohen SM (1998b). Urinary bladder carcinogenesis. Toxicol Pathol, 26, 121-7.
4. Cohen SM (2004). Human carcinogenic risk evaluation: An alternative approach to the two-year rodent bioassay. Toxicol Sci, 8, 225-9.
5. Cohen SM, Ellwein LB (1990). Proliferative and genotoxic cellular effects in 2-acetylaminofluorene bladder and liver carcinogenesis: Biological modeling of the ED01 study. Toxicol Appl Pharmacol, 104, 79-93.
6. Cohen SM, Ellwein LB (1991). Genetic errors, cell proliferation, and carcinogenesis. Cancer Res, 51, 6493-505.
7. Cohen SM, Purtilo DT, Ellwein LB (1991). Pivotal role of increased cell proliferation in human carcinogenesis. Modern Pathol, 4, 371-82.
8. Cohen SM, Shirai T, Steineck G (2000). Epidemiology and etiology of premalignant and malignant urothelial changes. Scand J Urol Nephrol, 205, 105-15.
9. Cohen SM, Klaunig J, Meek ME, et al (2004). Evaluating the human relevance of chemically-induced animal tumors. Toxicol Sci, 78, 181-6.
10. Cohen SM, Boobis AR, Meek ME, Preston RJ, McGregor DB (2006). 4-Aminobiphenyl and DNA reactivity: case study within the context of the 2006 IPCS human relevance framework for analysis of a cancer mode of action for humans. Crit Rev Toxicol, 36, 803-19.
11. Cohen SM, Ohnishi T, Clark NM, He J, Arnold LL (2007). Investigations of rodent urinary bladder carcinogens: collection, processing, and evaluation of urine and bladders. Toxicol Pathol, 35 337-47.
12. Greenfield RE, Ellwein LB, Cohen SM (1984). A general probabilistic model of carcinogenesis: Analysis of experimental urinary bladder cancer. Carcinogenesis, 5, 437-45.
13. IARC Working Group (1999). Consensus Report. International Agency for Research on Cancer, IARC Scientific Publications, 147, 1-32,.
14. Meek ME, Bucher JR, Cohen SM, et al (2003). A framework for human relevance analysis of information on carcinogenic modes of action. Crit Rev Toxicol, 33, 591-653.
15. Seed et al (2005). Using mode of action and life stage information to evaluate the human relevance of animal toxicity data. Crit Rev Toxicol, 35, 663-72.